Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Effects on MER in DBS
NCT00608231Phase 3Withdrawn
- Sponsor
- Vanderbilt University
- Start
- Jan 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in Parkinson's disease (PD), essential tremor (ET), dystonia, sponsored by Vanderbilt University. Planned start Jan 2008; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
Parkinson's disease (PD)essential tremor (ET)dystonia
Beyond the preview
Go deeper on NCT00608231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608231.